In: Clinical & Experimental Metastasis, 2015, vol. 32, no. 7, p. 677-687
|
In: Journal of Molecular Medicine, 2015, vol. 93, no. 2, p. 159-164
|
In: Plos one, 2013, vol. 8, no. 9, p. e74045
More effective treatment of metastasizing osteosarcoma with a current mean 5-year survival rate of less than 20% requires more detailed knowledge on mechanisms and key regulatory molecules of the complex metastatic process. CXCR4, the receptor of the chemokine CXCL12, has been reported to promote tumor progression and metastasis in osteosarcoma. CXCR7 is a recently deorphanized...
|
In: Clinical & Experimental Metastasis, 2014, vol. 31, no. 3, p. 339-349
|
In: Cancer Immunology, Immunotherapy, 2014, vol. 63, no. 6, p. 571-580
|
In: Frontiers in Bioengineering and Biotechnology, 2018, vol. 6, p. -
Colorectal cancer (CRC) is the third cause of cancer-related mortality in industrialized countries. Local invasion and metastasis formation are events associated with poor prognosis for which today there are no effective therapeutic options. Invasion and metastasis are strongly modulated by cells of the tumor microenvironment (TME), in particular fibroblasts and endothelial cells. Unraveling...
|
In: Abdominal Imaging, 2010, vol. 35, no. 5, p. 528-536
|
In: Lung, 2012, vol. 190, no. 6, p. 691-695
|
In: World Journal of Surgery, 2012, vol. 36, no. 2, p. 386-391
|
In: Journal of Gastrointestinal Surgery, 2009, vol. 13, no. 10, p. 1781-1790
|